Skip to content

AMBQ AMBQ Non Cash Deferred Offering Costs

Non Cash Deferred Offering Costs at other companies

Navan, Inc.
 logo
Navan, Inc. NAVN
$407K
Enliven Therapeutics logo
Enliven TherapeuticsELVN
$217K
Sonida Senior Living logo
Sonida Senior LivingSNDA
$0
Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
$200K-33.3%
NetSTREIT logo
NetSTREITNTST
$259K-20.0%
NTS
Netskope, Inc. Class A Common StockNTSK
$0-100%

Other financials

Income statement

See full
Revenue$25.1M+59.3%
Gross profit$10.9M+29.8%
Operating income-$11.7M-33.7%
Net income-$10.2M-22.8%
EPS (diluted)-$0.50+97.4%

Balance sheet

See full
Cash & equivalents$204.5M
Total debt$2.1M
Total equity$235.2M+178%
Total assets$259.5M

Cash flow

See full
Operating cash flow-$11.2M-895%

Valuation

See full
Market cap$1.74B
Enterprise value$1.54B
P/S21.3×

Profitability

See full
Gross margin42.3%+7.7pp
Operating margin-51.9%-0.5pp
Net margin-46.9%-3.0pp

Returns & leverage

See full
Return on equity118.8%
Debt / equity
Current ratio11.7×

Where this comes from

Reported directly by AMBQ in its filing.

Tagged under the XBRL concept ambq:NonCashDeferredOfferingCosts.

The official record: AMBQ’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about AMBQ's non cash deferred offering costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AMBQ's non cash deferred offering costs?
AMBQ (AMBQ) reported non cash deferred offering costs of -$75K in Q4 2025.
What does non cash deferred offering costs mean?
This metric captures costs associated with equity or debt offerings that have been incurred but not yet settled in cash, or that have been reclassified from deferred assets to equity. It highlights non-cash accounting adjustments related to capital raising activities. Investors monitor this to distinguish between actual cash outflows for financing and accounting-driven adjustments to equity issuance costs.